ACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreThe U.S. Federal Trade Commission, Department of Justice (DOJ), and the Department of Health and Human Services (HHS) launched a public inquiry into private equity and other corporations’ increasing control over healthcare. A press release announcing the initiative noted the growing involvement of private equity firms and corporate owners in healthcare and suggests that this may lead to “a maximizing of profits at the expense of quality care.”
The agencies issued a Request for Information (RFI) requesting public comment on deals conducted by health systems, private payers, private equity funds and other alternative asset managers that involve healthcare providers, facilities, or ancillary products or services. The inquiry seeks to understand “how certain healthcare market transactions may increase consolidation and generate profits for firms while threatening patients’ health, workers’ safety, quality of care, and affordable healthcare for patients and taxpayers.” Comments are due by May 6.
For more information, contact Gloria Romanelli, American College of Radiology® Senior Director, Legislative and Regulatory Relations, Legal Counsel, Quality and Safety.
ACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreAC Update Regards Lung Diseases
Stay current with ACR Appropriateness Criteria updates featuring new and revised guidance for lung disease imaging.
Read moreFY27 NIH Appropriations
ACR urges Congress to finalize FY27 NIH funding, protecting biomedical research, medical innovation and advances in patient care.
Read more